Myocyte-specific enhancer factor 2A
(Redirected from MEF2A)
Myocyte-specific enhancer factor 2A (MEF2A) is a protein that in humans is encoded by the MEF2A gene. This protein is a member of the myocyte enhancer factor 2 (MEF2) family of transcription factors, which play crucial roles in the regulation of gene expression in muscle cells and other tissues.
Structure[edit | edit source]
MEF2A contains a highly conserved MADS-box domain and an adjacent MEF2 domain, which are essential for DNA binding and dimerization. The protein also has regions that mediate interactions with other transcription factors and coactivators, facilitating the regulation of target gene expression.
Function[edit | edit source]
MEF2A is involved in the regulation of muscle cell differentiation and development. It binds to specific DNA sequences in the promoter regions of target genes, activating their transcription. MEF2A is also implicated in various cellular processes, including cell cycle regulation, apoptosis, and signal transduction pathways.
Role in Disease[edit | edit source]
Mutations in the MEF2A gene have been associated with coronary artery disease (CAD) and myocardial infarction. Research suggests that these mutations may disrupt the normal function of MEF2A, leading to impaired cardiovascular health.
Interactions[edit | edit source]
MEF2A interacts with several other proteins, including histone deacetylases (HDACs), coactivators, and other transcription factors. These interactions are critical for the modulation of MEF2A activity and the fine-tuning of gene expression.
Related Proteins[edit | edit source]
Other members of the MEF2 family include MEF2B, MEF2C, and MEF2D. These proteins share similar structural features and functions but have distinct roles in different tissues and developmental stages.
Research and Applications[edit | edit source]
MEF2A is a subject of ongoing research, particularly in the context of cardiovascular disease and muscle biology. Understanding the mechanisms by which MEF2A regulates gene expression may lead to new therapeutic strategies for treating related conditions.
See Also[edit | edit source]
- Myocyte enhancer factor 2
- Transcription factor
- Gene expression
- Muscle cell
- Coronary artery disease
- Myocardial infarction
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
